Potomac Fund Management Inc /Adv Astrazeneca PLC Transaction History
Potomac Fund Management Inc /Adv
- $112 Billion
- Q4 2024
A detailed history of Potomac Fund Management Inc /Adv transactions in Astrazeneca PLC stock. As of the latest transaction made, Potomac Fund Management Inc /Adv holds 16,763 shares of AZN stock, worth $1.25 Million. This represents 0.98% of its overall portfolio holdings.
Number of Shares
16,763Holding current value
$1.25 Million% of portfolio
0.98%Shares
1 transactions
Others Institutions Holding AZN
# of Institutions
1,343Shares Held
477MCall Options Held
5.29MPut Options Held
3.79M-
Price T Rowe Associates Inc Baltimore, MD62.9MShares$4.68 Billion0.56% of portfolio
-
Primecap Management CO Pasadena, CA41MShares$3.05 Billion2.12% of portfolio
-
Wellington Management Group LLP Boston, MA37MShares$2.76 Billion0.46% of portfolio
-
Capital International Investors Los Angeles, CA36.8MShares$2.74 Billion0.57% of portfolio
-
Franklin Resources Inc San Mateo, CA19.5MShares$1.45 Billion0.37% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $231B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...